141 related articles for article (PubMed ID: 34161676)
1. Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity.
Yilmaz E; Gan GN; Schroeder TM; Cowan A; Joste N
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1363. PubMed ID: 34161676
[TBL] [Abstract][Full Text] [Related]
2. Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
Daher T; Tur MK; Brobeil A; Etschmann B; Witte B; Engenhart-Cabillic R; Krombach G; Blau W; Grimminger F; Seeger W; Klussmann JP; Bräuninger A; Gattenlöhner S
Head Neck; 2018 Jun; 40(6):1109-1119. PubMed ID: 29522268
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
[TBL] [Abstract][Full Text] [Related]
4. Late (> 5 years) regional lymph node metastasis of oral squamous cell carcinoma (SCC), proven by p53 mutation analysis.
Hoekstra JW; Kummer JA; van Es RJ
J Craniomaxillofac Surg; 2008 Oct; 36(7):415-8. PubMed ID: 18554920
[TBL] [Abstract][Full Text] [Related]
5. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing.
Lilja-Fischer JK; Saksø M; Stougaard M; Steiniche T; Overgaard J
Acta Oncol; 2019 Oct; 58(10):1506-1508. PubMed ID: 31271080
[No Abstract] [Full Text] [Related]
7. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
[TBL] [Abstract][Full Text] [Related]
9. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
[TBL] [Abstract][Full Text] [Related]
10. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification.
Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718
[TBL] [Abstract][Full Text] [Related]
11. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.
Ogi K; Kobayashi J; Nakagaki T; Okamoto J; Koike K; Hirokawa N; Someya M; Sakamoto H; Takada K; Tokino T; Sasaki Y; Hiratsuka H; Miyazaki A
Oral Oncol; 2020 Mar; 102():104509. PubMed ID: 31839407
[No Abstract] [Full Text] [Related]
13. Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma.
Ramakrishnan K; Liu Z; Baxi S; Chandwani S; Joo S; Chirovsky D
Future Oncol; 2021 Aug; 17(23):3037-3050. PubMed ID: 34044594
[TBL] [Abstract][Full Text] [Related]
14. Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma.
Wakasaki T; Yasumatsu R; Uchi R; Taura M; Matsuo M; Komune N; Nakagawa T
Auris Nasus Larynx; 2020 Feb; 47(1):116-122. PubMed ID: 31128940
[TBL] [Abstract][Full Text] [Related]
15. KRT13 and UPK1B for differential diagnosis between metastatic lung carcinoma from oral squamous cell carcinoma and lung squamous cell carcinoma.
Goda H; Nakashiro KI; Sano Y; Adachi T; Tokuzen N; Kuribayashi N; Hino S; Uchida D
Sci Rep; 2023 Dec; 13(1):22626. PubMed ID: 38114532
[TBL] [Abstract][Full Text] [Related]
16. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological prognostic factors of oral squamous cell carcinoma: An experience of a tertiary care hospital.
Abbas SA; Saeed J; Tariq MU; Baksh AR; Hashmi S
J Pak Med Assoc; 2018 Jul; 68(7):1115-1119. PubMed ID: 30317316
[TBL] [Abstract][Full Text] [Related]
18. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.
Ludwig ML; Kulkarni A; Birkeland AC; Michmerhuizen NL; Foltin SK; Mann JE; Hoesli RC; Devenport SN; Jewell BM; Shuman AG; Spector ME; Carey TE; Jiang H; Brenner JC
Oral Oncol; 2018 Dec; 87():144-151. PubMed ID: 30527230
[TBL] [Abstract][Full Text] [Related]
19. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
